Abstract
In this issue of Blood, Leleu and colleagues1 and Richardson and colleagues2 publish two different trials using pomalidomide and dexamethasone in patients with relapsed and refractory multiple myeloma (MM).
Original language | English (US) |
---|---|
Pages (from-to) | 1926-1928 |
Number of pages | 3 |
Journal | Blood |
Volume | 121 |
Issue number | 11 |
DOIs |
|
State | Published - 2013 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology